{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:31:08Z","timestamp":1780108268024,"version":"3.54.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12015-020-10017-6","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T11:02:35Z","timestamp":1596279755000},"page":"144-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients"],"prefix":"10.1007","volume":"17","author":[{"given":"Diana","family":"Esquivel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangnath","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhat","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasekar","family":"Seetharaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjum","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"10017_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jgar.2020.02.021","volume":"21","author":"T Lupia","year":"2020","unstructured":"Lupia, T., Scabini, S., Mornese Pinna, S., Di Perri, G., De Rosa, F. G., & Corcione, S. (2020). 2019 novel coronavirus (2019-NCoV) outbreak: A new challenge. Journal of Global Antimicrobial Resistanc, 21, 22\u201327.","journal-title":"Journal of Global Antimicrobial Resistanc"},{"key":"10017_CR2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020). Clinical features of patients infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497\u2013506.","journal-title":"The Lancet"},{"key":"10017_CR3","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., et al. (2003). A novel coronavirus associated with severe acute respiratory syndrome. The New England Journal of Medicine, 348, 1953\u20131966.","journal-title":"The New England Journal of Medicine"},{"key":"10017_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","volume":"362","author":"T Kuiken","year":"2003","unstructured":"Kuiken, T., Fouchier, R. A., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., et al. (2003). Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. The Lancet, 362, 263\u2013270.","journal-title":"The Lancet"},{"key":"10017_CR5","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1126\/science.1092002","volume":"303","author":"The Chinese SARS Molecular Epidemiology Consortium","year":"2004","unstructured":"The Chinese SARS Molecular Epidemiology Consortium. (2004). Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science, 303, 1666\u20131669.","journal-title":"Science"},{"key":"10017_CR6","doi-asserted-by":"crossref","unstructured":"Shi, Z., & Hu, Z. A. (2008). Review of studies on animal reservoirs of the SARS coronavirus. Virus Research, 133, 74\u201387.","DOI":"10.1016\/j.virusres.2007.03.012"},{"key":"10017_CR7","doi-asserted-by":"crossref","unstructured":"Coleman, C. M., Frieman, M. B., & Coronaviruses (2014). Important emerging human pathogens. Journal of Virology, 88, 5209\u20135212.","DOI":"10.1128\/JVI.03488-13"},{"key":"10017_CR8","doi-asserted-by":"crossref","unstructured":"van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012). Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio, 3, e00473\u2013e00471.","DOI":"10.1128\/mBio.00473-12"},{"key":"10017_CR9","doi-asserted-by":"crossref","unstructured":"Reusken, C. B. E. M., Haagmans, B. L., M\u00fcller, M. A., Gutierrez, C., Godeke, G.-J., Meyer, B., Muth, D., Raj, V. S., Smits-De Vries, L., Corman, V. M., et al. (2013). Middle east respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. The Lancet, 13, 859\u2013866, S1473-3099(13)70164-6.","DOI":"10.1016\/S1473-3099(13)70164-6"},{"key":"10017_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","volume":"14","author":"BL Haagmans","year":"2014","unstructured":"Haagmans, B. L., Dhahiry, S. H. S. A., Reusken, C. B. E. M., Raj, V. S., Galiano, M., Myers, R., et al. (2014). Middle east respiratory syndrome coronavirus in dromedary camels: An outbreak investigation. The Lancet, 14, 140\u2013145. https:\/\/doi.org\/10.1016\/S1473-3099(13)70690-X","journal-title":"The Lancet"},{"key":"10017_CR11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1164\/rccm.201202-0228PP","volume":"185","author":"DN Kotton","year":"2012","unstructured":"Kotton, D. N. (2012). Next-generation regeneration. American Journal of Respiratory and Critical Care Medicine, 185, 1255\u20131260.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10017_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/stem.1506","volume":"32","author":"DJ Weiss","year":"2014","unstructured":"Weiss, D. J. (2014). Concise review: Current status of stem cells and regenerative medicine in lung biology and diseases. Stem Cells, 32, 16\u201325.","journal-title":"Stem Cells"},{"key":"10017_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/sci.2017.01.02","volume":"4","author":"FF Cruz","year":"2017","unstructured":"Cruz, F. F., & Rocco, P. R. M. (2017). Stem-Cell extracellular vesicles and lung repair. Stem Cell Investigation, 4, 1\u201311.","journal-title":"Stem Cell Investigation"},{"key":"10017_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/17476348.2020.1679628","volume":"14","author":"FF Cruz","year":"2020","unstructured":"Cruz, F. F., & Rocco, P. R. M. (2020). The potential of mesenchymal stem cell therapy for chronic lung disease. Expert Review of Respiratory Medicine, 14, 31\u201339.","journal-title":"Expert Review of Respiratory Medicine"},{"key":"10017_CR15","doi-asserted-by":"crossref","unstructured":"Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., Gao, G. F., & Epidemiology (2016). Genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24, 490\u2013502.","DOI":"10.1016\/j.tim.2016.03.003"},{"key":"10017_CR16","doi-asserted-by":"crossref","unstructured":"Hu, D., Zhu, C., Ai, L., He, T., Wang, Y., Ye, F., Yang, L., Ding, C., Zhu, X., Lv, R., et al. (2018). Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats. Emerging Microbes & Infections, 7, 1\u201310.","DOI":"10.1038\/s41426-018-0155-5"},{"key":"10017_CR17","doi-asserted-by":"crossref","unstructured":"Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. The Lancet, 395, 565\u2013574.","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"10017_CR18","doi-asserted-by":"crossref","unstructured":"Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kr\u00fcger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor. Cell, 181, 1\u201310.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"10017_CR19","doi-asserted-by":"crossref","unstructured":"Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Letters to nature, 426, 450\u2013454.","DOI":"10.1038\/nature02145"},{"key":"10017_CR20","doi-asserted-by":"publisher","unstructured":"Mousavizadeh, L., & Ghasemi, S. (2020). Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of Microbiology, Immunology and Infection. https:\/\/doi.org\/10.1016\/j.jmii.2020.03.022.","DOI":"10.1016\/j.jmii.2020.03.022"},{"key":"10017_CR21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I., Timens, W., Bulthuis, M. L. C., Lely, A. T., Navis, G. J., & van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathology, 203, 631\u2013637.","journal-title":"Journal of Pathology"},{"key":"10017_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-virology-100114-055218","volume":"2","author":"I Sola","year":"2015","unstructured":"Sola, I., Almaz\u00e1n, F., Z\u00fa\u00f1iga, S., & Enjuanes, L. (2015). Continuous and discontinuous RNA synthesis in coronaviruses. Annual Review of Virology, 2, 265\u2013288.","journal-title":"Annual Review of Virology"},{"key":"10017_CR23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N., Zhou, M., Dong, X., Qu, J., Han, Y., Qiu, Y., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395, 507\u2013513.","journal-title":"The Lancet"},{"key":"10017_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.00001","volume":"10","author":"L Guo","year":"2019","unstructured":"Guo, L., Wei, D., Zhang, X., Wu, Y., Li, Q., Zhou, M., & Qu, J. (2019). Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA score. Frontiers in Microbiology, 10, 1\u201310.","journal-title":"Frontiers in Microbiology"},{"key":"10017_CR25","doi-asserted-by":"publisher","unstructured":"Guan, W., Liang, W., Zhao, Y., Liang, H., Chen, Z., Li, Y., Liu, X., Chen, R., Tang, C., Wang, T., et al. (2020). Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis. European Respiratory Journal , in press. https:\/\/doi.org\/10.1183\/13993003.00547-2020.","DOI":"10.1183\/13993003.00547-2020"},{"key":"10017_CR26","doi-asserted-by":"publisher","unstructured":"Lippi, G., Plebani, M. (2020). Laboratory abnormalities in patients with COVID-2019 infection. Clinical Chemistry and Laboratory Medicine, in press. https:\/\/doi.org\/10.1515\/cclm-2020-0198.","DOI":"10.1515\/cclm-2020-0198"},{"key":"10017_CR27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore, J. B., & June, C. H. (2020). Cytokine release syndrome in severe COVID-19. Science, 368, 473\u2013474.","journal-title":"Science"},{"key":"10017_CR28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D., Hu, B., Hu, C., Zhu, F., et al. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA, 323, 1061.","journal-title":"JAMA"},{"key":"10017_CR29","doi-asserted-by":"crossref","unstructured":"Klok, F. A., Kruip, N. J. M., der Meer, M. S., Arbous, D. A. M., et al. (2020). Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research, 2020, https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7146714\/.","DOI":"10.1016\/j.thromres.2020.04.013"},{"key":"10017_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jinf.2020.02.018","volume":"80","author":"S Tian","year":"2020","unstructured":"Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., et al. (2020). Characteristics of COVID-19 infection in Beijing. Journal of Infection, 80, 401\u2013406.","journal-title":"Journal of Infection"},{"key":"10017_CR31","unstructured":"Luo, W., Yu, H., Gou, J., Li, X., Sun, Y., Li, J., & Liu, L. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints, 2020, 2020020407."},{"key":"10017_CR32","doi-asserted-by":"crossref","unstructured":"Lee, K. D., Kuo, T. K., Whang-Peng, J.; et al. (2004).\u00a0In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology,\u00a040, 1275\u20131284.","DOI":"10.1002\/hep.20469"},{"key":"10017_CR33","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1634\/stemcells.2005-0636","volume":"24","author":"P Tropel","year":"2006","unstructured":"Tropel, P., Platet, N., Platel, J. C., et al. (2006). Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells, 24, 2868\u20132876.","journal-title":"Stem Cells"},{"key":"10017_CR34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.advms.2014.08.001","volume":"59","author":"MZ Ratajczak","year":"2014","unstructured":"Ratajczak, M. Z., Marycz, K., Poniewierska-Baran, A., Fiedorowicz, A., Zbucka-Kretowskae, M., & Moniuszkof, M. (2014). Very small embryonic-like stem cells as a novel developmental concept and the hierarchy of the stem cell compartment. Advances in Medical Sciences, 59, 273\u2013280.","journal-title":"Advances in Medical Sciences"},{"key":"10017_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar2116","volume":"9","author":"CM Kolf","year":"2007","unstructured":"Kolf, C. M., Cho, E., & Tuan, R. S. (2007). Biology of adult mesenchymal stem cells: Regulation of niche, self-renewal and differentiation. Arthritis Research & Therapy, 9, 204. https:\/\/doi.org\/10.1186\/ar2116","journal-title":"Arthritis Research & Therapy"},{"key":"10017_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","volume":"6","author":"JD Glenn","year":"2014","unstructured":"Glenn, J. D., & Whartenby, K. A. (2014). Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World Journal of Stem Cells, 6, 526. https:\/\/doi.org\/10.4252\/wjsc.v6.i5.526","journal-title":"World Journal of Stem Cells"},{"key":"10017_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/379093","author":"M Mar\u0119dziak","year":"2015","unstructured":"Mar\u0119dziak, M., \u015amieszek, A., Chrz\u0105stek, K., Basinska, K., & Marycz, K. (2015). Physical Activity increases the total number of bone-marrow-derived mesenchymal stem cells, enhances their osteogenic potential, and inhibits their adipogenic properties. Stem Cells International. https:\/\/doi.org\/10.1155\/2015\/379093","journal-title":"Stem Cells International"},{"key":"10017_CR38","doi-asserted-by":"crossref","unstructured":"Mar\u0119dziak, M., Marycz, K., Tomaszewski, K., Kornicka, K. A., K., and Henry, B. M. B. (2016). The influence of aging on the regenerative potential of human adipose derived mesenchymal stem cells. Stem Cells International 2016, Article ID# 2152435.","DOI":"10.1155\/2016\/2152435"},{"key":"10017_CR39","doi-asserted-by":"crossref","unstructured":"Yang, J., & Jia, Z. (2014). Cell-based therapy in lung regenerative medicine. Regenerative Medicine Research, 2, 1\u20137.","DOI":"10.1186\/2050-490X-2-7"},{"key":"10017_CR40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/jcm9030682","volume":"9","author":"J Behnke","year":"2020","unstructured":"Behnke, J., Kremer, S., Shahzad, T., Chao, C.-M., B\u00f6ttcher-Friebertsh\u00e4user, E., Morty, R. E., et al. (2020). MSC based therapies\u2014New perspectives for the injured lung. Journal of Clinical Medicine, 9, 682.","journal-title":"Journal of Clinical Medicine"},{"key":"10017_CR41","doi-asserted-by":"crossref","unstructured":"Weiss, D. J. (2010). Mesenchymal stem cells for lung repair and regeneration. In M. Rojas (Ed.), Stem cells in the respiratory system (pp.\u00a025\u201342). New York: Springer Science & Business Media.","DOI":"10.1007\/978-1-60761-775-4_2"},{"key":"10017_CR42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","volume":"20","author":"L da Silva Meirelles","year":"2009","unstructured":"da Silva Meirelles, L., Fontes, A. M., Covas, D. T., & Caplan, A. I. (2009). Mechanisms involved in the therapeutic properties of Mesenchymal stem cells. Cytokine & Growth Factor Reviews, 20, 419\u2013427.","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10017_CR43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI0214941","volume":"109","author":"KA Frauwirth","year":"2002","unstructured":"Frauwirth, K. A., & Thompson, C. B. (2002). Activation and inhibition of lymphocytes by Costimulation. Journal of Clinical Investigation, 109, 295\u2013299.","journal-title":"Journal of Clinical Investigation"},{"key":"10017_CR44","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","volume":"105","author":"S Glennie","year":"2005","unstructured":"Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W.-F., & Dazzi, F. (2005). Bone marrow Mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105, 2821\u20132827.","journal-title":"Blood"},{"key":"10017_CR45","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","volume":"117","author":"JS Rawlings","year":"2004","unstructured":"Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004). The JAK\/STAT signaling pathway. Journal of Cell Science, 117, 1281\u20131283.","journal-title":"Journal of Cell Science"},{"key":"10017_CR46","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel, R., Zibert, A., Laryea, M., G\u00f6bel, U., D\u00e4ubener, W., & Dilloo, D. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase\u2013mediated tryptophan degradation. Blood, 103, 4619\u20134621.","journal-title":"Blood"},{"key":"10017_CR47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/vaccines3030703","volume":"3","author":"J Mbongue","year":"2015","unstructured":"Mbongue, J., Nicholas, D., Torrez, T., Kim, N.-S., Firek, A., & Langridge, W. (2015). The role of indoleamine 2, 3-dioxygenase in immune suppression and autoimmunity. Vaccines, 3, 703\u2013729.","journal-title":"Vaccines"},{"key":"10017_CR48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","volume":"149","author":"JM Ryan","year":"2007","unstructured":"Ryan, J. M., Barry, F., Murphy, J. M., & Mahon, B. P. (2007). Interferon-\u03b3 does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clinical and Experimental Immunology, 149, 353\u2013363.","journal-title":"Clinical and Experimental Immunology"},{"key":"10017_CR49","first-page":"1","volume":"2014","author":"R Haddad","year":"2014","unstructured":"Haddad, R., & Saldanha-Araujo, F. (2014). Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: What do we know so far? BioMed Research International, 2014, 1\u201314.","journal-title":"BioMed Research International"},{"key":"10017_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2006.00739.x","volume":"69","author":"J Stagg","year":"2007","unstructured":"Stagg, J. (2007). Immune regulation by mesenchymal stem cells: Two sides to the coin. Tissue Antigens, 69, 1\u20139.","journal-title":"Tissue Antigens"},{"key":"10017_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/976793","volume":"2011","author":"J Briones","year":"2011","unstructured":"Briones, J., Novelli, S., & Sierra, J. (2011). T.-cell costimulatory molecules in acute-graft-versus host disease: Therapeutic implications. Journal of Bone Marrow Research, 2011, 1\u20137.","journal-title":"Journal of Bone Marrow Research"},{"key":"10017_CR52","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s12015-012-9408-1","volume":"8","author":"M Najar","year":"2012","unstructured":"Najar, M., Raicevic, G., Kazan, H. F., De Bruyn, C., Bron, D., Toungouz, M., & Lagneaux, L. (2012). Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: The expression and impact of inflammatory priming. Stem Cell Reviews and Reports, 8, 1188\u20131198.","journal-title":"Stem Cell Reviews and Reports"},{"key":"10017_CR53","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4049\/jimmunol.180.3.1598","volume":"180","author":"Y-P Li","year":"2008","unstructured":"Li, Y.-P., Paczesny, S., Lauret, E., Poirault, S., Bordigoni, P., Mekhloufi, F., et al. (2008). Human mesenchymal stem cells license adult CD34 + hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the notch pathway. Journal of Immunology, 180, 1598\u20131608.","journal-title":"Journal of Immunology"},{"key":"10017_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocit.2018.09.001","volume":"4","author":"G Qu","year":"2018","unstructured":"Qu, G., Xie, X., Li, X., Chen, Y., Isla, N. D., Huselstein, C., et al. (2018). Immunomodulatory function of mesenchymal stem cells: Regulation and application. Journal of Cellular Immunotherapy, 4, 1\u20133.","journal-title":"Journal of Cellular Immunotherapy"},{"key":"10017_CR55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.scr.2011.04.001","volume":"7","author":"F Saldanha-Araujo","year":"2011","unstructured":"Saldanha-Araujo, F., Ferreira, F. I. S., Palma, P. V., Araujo, A. G., Queiroz, R. H. C., Covas, D. T., et al. (2011). Mesenchymal Stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes. Stem Cell Research, 7, 66\u201374.","journal-title":"Stem Cell Research"},{"key":"10017_CR56","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2006-06-028704","volume":"109","author":"M Pevsner-Fischer","year":"2007","unstructured":"Pevsner-Fischer, M., Morad, V., Cohen-Sfady, M., Rousso-Noori, L., Zanin-Zhorov, A., Cohen, S., et al. (2007). Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood, 109, 1422\u20131432.","journal-title":"Blood"},{"key":"10017_CR57","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1089\/ten.tea.2008.0340","volume":"15","author":"E Lombardo","year":"2009","unstructured":"Lombardo, E., DelaRosa, O., Manche\u00f1o-Corvo, P., Menta, R., Ram\u00edrez, C., & B\u00fcscher, D. (2009). Toll-like receptor\u2013mediated signaling in human adipose-derived stem cells: Implications for immunogenicity and immunosuppressive potential. Tissue Engineering, 15, 1579\u20131589.","journal-title":"Tissue Engineering"},{"key":"10017_CR58","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1634\/stemcells.2006-0189","volume":"24","author":"H Hwa Cho","year":"2006","unstructured":"Hwa Cho, H., Bae, Y. C., & Jung, J. S. (2006). Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells, 24, 2744\u20132752.","journal-title":"Stem Cells"},{"key":"10017_CR59","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/stem.7","volume":"27","author":"CA Opitz","year":"2009","unstructured":"Opitz, C. A., Litzenburger, U. M., Lutz, C., Lanz, T. V., Tritschler, I., K\u00f6ppel, A., et al. (2009). Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-\u03b2 and protein kinase R. Stem Cells, 27, 909\u2013919.","journal-title":"Stem Cells"},{"key":"10017_CR60","doi-asserted-by":"crossref","unstructured":"Sabroe, I., Read, R. C., Whyte, M. K. B., Dockrell, D. H., Vogel, S. N., & Dower, S. K. (2003). Toll-Like Receptors in Health and Disease: Complex Questions Remain. J Immunol, 171, 1630\u20131635.","DOI":"10.4049\/jimmunol.171.4.1630"},{"key":"10017_CR61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt34","volume":"1","author":"BA Bunnell","year":"2010","unstructured":"Bunnell, B. A., Betancourt, A. M., & Sullivan, D. E. (2010). New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Research & Therapy, 1, 34.","journal-title":"Stem Cell Research & Therapy"},{"key":"10017_CR62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.humimm.2009.12.005","volume":"71","author":"G Raicevic","year":"2010","unstructured":"Raicevic, G., Rouas, R., Najar, M., Stordeur, P., Id Boufker, H., Bron, D., et al. (2010). Inflammation modifies the pattern and the function of toll-like receptors expressed by human mesenchymal stromal cells. Human Immunology, 71, 235\u2013244.","journal-title":"Human Immunology"},{"key":"10017_CR63","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.yexcr.2006.03.019","volume":"312","author":"I Rasmusson","year":"2006","unstructured":"Rasmusson, I. (2006). Immune modulation by mesenchymal stem cells. Experimental Cell Research, 312, 2169\u20132179.","journal-title":"Experimental Cell Research"},{"key":"10017_CR64","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","volume":"7","author":"F Gao","year":"2016","unstructured":"Gao, F., Chiu, S. M., Motan, D. A. L., Zhang, Z., Chen, L., Ji, H.-L., et al. (2016). Mesenchymal stem cells and immunomodulation: Current status and future prospects. Cell Death & Disease, 7, e2062\u2013e2062.","journal-title":"Cell Death & Disease"},{"key":"10017_CR65","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1242\/dev.01706","volume":"132","author":"D James","year":"2005","unstructured":"James, D., Levine, A. J., Besser, D., & Hermmati-Brivanlou, A. (2005). TGF\u03b2\/activin\/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development, 132, 1273\u20131282.","journal-title":"Development"},{"key":"10017_CR66","doi-asserted-by":"crossref","unstructured":"Chu, X., Chen, C., Chen, C., Zhang, J.-S., Bellusci, S., & Li, X. Evidence for Lung Repair and Regeneration in Humans: Key Stem Cells and Therapeutic Functions of Fibroblast Growth Factors. Frontiers of Medicine, 2019, 1\u201311.","DOI":"10.1007\/s11684-019-0717-5"},{"key":"10017_CR67","doi-asserted-by":"crossref","first-page":"L742","DOI":"10.1152\/ajplung.00064.2006","volume":"292","author":"MK Sakurai","year":"2007","unstructured":"Sakurai, M. K., Lee, S., Arsenault, D. A., Nose, V., Wilson, J. M., Heymach, J. V., & Puder, M. (2007). Vascular endothelial growth factor accelerates compensatory lung growth after unilateral pneumonectomy. The American Journal of Physiology-Lung C, 292, L742\u2013L747.","journal-title":"The American Journal of Physiology-Lung C"},{"key":"10017_CR68","doi-asserted-by":"crossref","unstructured":"Medford, A. R. L., Millar, A. B. (2006). Vascular Endothelial Growth Factor (VEGF) in Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS): Paradox or Paradigm? Thorax, 61, 621\u2013626.","DOI":"10.1136\/thx.2005.040204"},{"key":"10017_CR69","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1067\/mtc.2000.110460","volume":"120","author":"AK Kaza","year":"2000","unstructured":"Kaza, A. K., Laubach, V. E., Kern, J. A., Long, S. M., Fiser, S. M., Tepper, J. A., et al. (2000). Epidermal growth factor augments postpneumonectomy lung growth. The Journal of Thoracic and Cardiovascular Surgery, 120, 916\u2013922.","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"key":"10017_CR70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/aps.2010.90","volume":"32","author":"RAM Panganiban","year":"2011","unstructured":"Panganiban, R. A. M., & Day, R. M. (2011). Hepatocyte growth factor in lung repair and pulmonary fibrosis. Acta Pharmaceutica Sinica, 32, 12\u201320.","journal-title":"Acta Pharmaceutica Sinica"},{"key":"10017_CR71","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1586\/eri.11.56","volume":"9","author":"I Darwish","year":"2011","unstructured":"Darwish, I., Mubareka, S., & Liles, W. C. (2011). Immunomodulatory therapy for severe influenza. Expert Review of Anti-infective Therapy, 9, 807\u2013822.","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10017_CR72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng, Z., Zhu, R., Hou, W., Feng, Y., et al. (2020). Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging and Disease, 11, 216.","journal-title":"Aging and Disease"},{"key":"10017_CR73","doi-asserted-by":"crossref","first-page":"462","DOI":"10.14336\/AD.2020.0301","volume":"11","author":"AK Shetty","year":"2020","unstructured":"Shetty, A. K. (2020). Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)- induced pneumonia. Aging and Disease, 11, 462.","journal-title":"Aging and Disease"},{"key":"10017_CR74","doi-asserted-by":"crossref","unstructured":"Liang, B., Chen, J., Li, T., Wu, H., Yang, W., Li, Y., Li, J., Yu, C., Nie, F., Ma, Z., et al. (2020). Clinical remission of a critically Ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells. ChinaXiv, 202002.00084.","DOI":"10.1097\/MD.0000000000021429"},{"key":"10017_CR75","doi-asserted-by":"publisher","unstructured":"Chen, J., Hu, C., Chen, L., Tang, L., Zhu, Y., Xu, X., Chen, L., Gao, H., Lu, X., Yu, L., et al. (2020). Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment. Engineering, in press. https:\/\/doi.org\/10.1016\/j.eng.2020.02.006.","DOI":"10.1016\/j.eng.2020.02.006"},{"key":"10017_CR76","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1042\/CBI20110026","volume":"35","author":"N Ma","year":"2011","unstructured":"Ma, N., Gai, H., Mei, J., Ding, F., Bao, C., Nguyen, D. M., & Zhong, H. (2011). Bone marrow mesenchymal stem cells can differentiate into type II alveolar epithelial cells in vitro. Cell Biology International, 35, 1261\u20131266.","journal-title":"Cell Biology International"},{"key":"10017_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-42819-1","volume":"9","author":"KT Leeman","year":"2019","unstructured":"Leeman, K. T., Pessina, P., Lee, J.-H., & Kim, C. F. (2019). Mesenchymal stem cells increase alveolar differentiation in lung progenitor organoid cultures. Scientific Reports, 9, 1\u201310.","journal-title":"Scientific Reports"},{"key":"10017_CR78","doi-asserted-by":"crossref","unstructured":"Wilson, J. G., Liu, K. D., Zhuo, N. J., Caballero, L., McMillan, M., Fang, X. H., et al. (2015). Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respiratory Medicine, 3, 24\u201332.","DOI":"10.1016\/S2213-2600(14)70291-7"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-020-10017-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T11:37:30Z","timestamp":1667648250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-020-10017-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10017"],"URL":"https:\/\/doi.org\/10.1007\/s12015-020-10017-6","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"1 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}